Related references
Note: Only part of the references are listed.Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression
Xu-Guang Mi et al.
TOXICOLOGY LETTERS (2014)
The Threonine Protease Activity of Testes-Specific Protease 50 (TSP50) Is Essential for Its Function in Cell Proliferation
Yu-Yin Li et al.
PLOS ONE (2012)
Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor κB (NF-κB) signalling pathway
Zhen-Bo Song et al.
BIOCHEMICAL JOURNAL (2011)
KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9
X. Wang et al.
ONCOGENE (2011)
High Expression of Testes-Specific Protease 50 Is Associated with Poor Prognosis in Colorectal Carcinoma
Lei Zheng et al.
PLOS ONE (2011)
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression
Eun-Jung Lee et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells
Yu Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line
Supachai Yodkeeree et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Knockdown of TSP50 Inhibits Cell Proliferation and Induces Apoptosis in P19 Cells
Liang Zhou et al.
IUBMB LIFE (2010)
The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions
Eresha Mendis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis
Bokyung Sung et al.
BLOOD (2008)
Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB-regulated antiapoptotic gene products, and potentiates apoptosis
Manoj K. Pandey et al.
CANCER RESEARCH (2008)
A microfluidic device for parallel 3-D cell cultures in asymmetric environments
Thomas Frisk et al.
ELECTROPHORESIS (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
A transgenic model reveals important roles for the NF-κB alternative pathway (p100/p52) in mammary development and links to tumorigenesis
Linda Connelly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Curcumin down regulates smokeless tobacco-induced NF-κB activation and COX-2 expression in human oral premalignant and cancer cells
Chhavi Sharma et al.
TOXICOLOGY (2006)
Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells:: NF-κB as a potential molecular target
JH Kim et al.
FEBS LETTERS (2006)
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells
MS Woo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway - Inhibitory effects of ascochlorin on the invasion of renal carcinoma cells
S Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB
Q Huang et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Axis of evil: molecular mechanisms of cancer metastasis
T Bogenrieder et al.
ONCOGENE (2003)
Multi-ethnic differences in breast cancer: Current concepts and future directions
NMA Perera et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix
KB Hotary et al.
CELL (2003)
Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells
TW Chung et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway
JF Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Matrix metalloproteinases in tumor invasion: Role for cell migration
K Nabeshima et al.
PATHOLOGY INTERNATIONAL (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough
U Cavallaro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2001)
Taking cell-matrix adhesions to the third dimension
E Cukierman et al.
SCIENCE (2001)
Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates
RM Merrill et al.
ANNALS OF EPIDEMIOLOGY (2001)
Share Paper
